Some crises arrive like a lightning strike. Others smolder for months before a single news report turns them into a national story. South Korean battery maker DN Automotive is living the second kind, and on Monday, October 12, its chief executive issued a public apology. The case offers hard lessons for any leader responsible for people who work in hazardous conditions.
One caution up front: the most serious allegations are still under investigation, and the line between verified and alleged matters.
What Happened
On Sunday, October 11, Korean broadcaster MBC reported that workers at DN Automotive’s automotive battery plant in Ulsan had repeatedly received chelation injections shortly before mandatory medical examinations, according to The Korea Herald. Chelation binds heavy metals such as lead so the body can excrete them. The injections were allegedly presented to workers as “vitamin shots.” The concern is that the treatments lowered workers’ blood lead levels ahead of required health screenings, hiding how much exposure they actually had.
The story did not start this week. According to Yonhap (Korean), the allegations were first raised in February at a press conference held by the Ulsan branch of the Korean Metal Workers’ Union and a workplace safety education center. The Elec reports that the Ministry of Employment and Labor received a whistleblower report in late January, conducted a special inspection from March 23 to April 17, found 68 violations of the Occupational Safety and Health Act, and ordered a partial work stoppage of lead-handling processes from April 21 to May 7. On August 13, the ministry asked police to investigate the company on suspicion of obstruction of business, and the Ulsan Metropolitan Police Agency is handling that inquiry. A joint committee of nine outside experts, nominated by labor, management and government, was established on October 8.
On October 12, President Lee Jae Myung ordered a thorough investigation. His spokesperson said the president called the alleged practice “a grave violation of human rights that can never be tolerated,” per The Korea Herald, and directed authorities to examine whether similar practices have occurred at other workplaces, according to Yonhap. That same day, DN Automotive posted a statement under the name of President and CEO Kim In-hwan apologizing and pledging cooperation, reported by the Seoul Economic Daily.
Verified vs. Alleged
Leaders reading crisis coverage should get in the habit of sorting claims into two columns. Based on reporting so far:
Established by official action or the company’s own words:
- The labor ministry found 68 workplace safety law violations at the plant, referred them to prosecutors and, per Yonhap, imposed fines of 46.2 million won.
- The ministry referred the company to police over the pre-exam injections, and police are investigating.
- A nine-member outside expert committee has been formed.
- The company has publicly apologized and committed to cooperate and to accept the committee’s findings.
Alleged and still under investigation:
- That injections were described to workers as vitamin shots.
- That the timing of the injections was intended to conceal blood lead levels from mandatory exams.
- The exact extent of workers’ exposure. The presidential office said lead concentrations exceeded permissible limits by more than fivefold, and the president ordered investigators to verify exposure levels.
It is also worth noting the company’s position. According to MBC’s reporting as cited by The Korea Herald, DN Automotive has denied forcing workers to receive the injections, maintaining that the treatments were voluntary. Earlier, per Yonhap, the company said it managed employee health using internal standards stricter than the legal requirements.
The Stakeholders
DN Automotive now has to address several audiences at once:
- Workers and their families, who are the people most directly affected and who need information about their own health above all else.
- The labor union, which raised the allegations publicly and now sits alongside management and government in the improvement process.
- Regulators, police and prosecutors.
- The national government, now engaged at the presidential level.
- Investors, customers and the Ulsan community, all watching whether the company can be trusted.
Assessing the Response Through SCCT
Situational Crisis Communication Theory (SCCT), developed by W. Timothy Coombs, ties the right response to how much responsibility stakeholders assign to the organization. Crises in the “preventable” cluster, where an organization is believed to have knowingly put people at risk, generate the strongest attributions of responsibility. SCCT recommends rebuilding strategies for those situations: full apology, corrective action and, where appropriate, compensation. If the allegations here are confirmed, this case sits squarely in that cluster.
Measured against that standard, the October 12 statement does several things well. It opens with a direct apology rather than a denial. It names a value the company failed to live up to: “We deeply regret that we failed to thoroughly uphold the principle that employee safety and health come first.” It commits to cooperating with investigations, health examinations and epidemiological surveys, and, importantly, it promises to accept the conclusions of an outside committee rather than grading its own homework.
There are also gaps. As the Seoul Economic Daily observed, the company “did not offer a detailed explanation of the allegations.” Its acceptance of responsibility is conditional: “If the findings show that the company bears any responsibility, we will accept it fully.” Lawyers will understand that phrasing; affected workers may hear it differently. And the apology arrived months after the allegations first surfaced, following a period in which the company’s public stance was that the treatments were voluntary. When an organization moves from defense to apology only after national media and the head of state weigh in, audiences tend to wonder whether the change reflects conviction or pressure.
What DN Automotive Should Do Next
- Put workers’ health information first. Affected employees need clear, direct communication about independent medical testing, what their results mean and where to get care. That message should reach them before it reaches the press.
- Reconcile the record. The company’s earlier “voluntary treatment” position and its current apology need to be explained in plain language. Silence on that question will be filled by others.
- Make the outside committee’s work visible. Commit publicly to releasing its findings and to a timeline for each corrective step.
- Communicate on a regular schedule. Steady updates show the company is not waiting for the next headline to speak.
Takeaways for Business Leaders
Having spent 14 years in broadcast media, including work overseeing public relations, I have seen how quickly a story that has lingered in local or trade coverage can become a national one. A few lessons apply well beyond battery manufacturing:
- Treat early warnings as the crisis. A whistleblower report or a union press conference is not a nuisance to be managed. It is the moment when an honest response costs the least.
- Never frame a health issue as a messaging issue. If what you tell employees about a procedure does not match what the procedure is, no communication strategy will survive the gap.
- Prepare for the apology before you need it. Know in advance who speaks, what you can say while investigations are ongoing and how to balance legal caution with human accountability.
- Invite independent eyes. Accepting outside review is one of the strongest credibility signals available to an organization under suspicion.
The DN Automotive story is still unfolding, and investigators, not commentators, will determine the facts. But the communication lesson is already clear: trust is easiest to protect long before the cameras arrive.
If your organization wants to stress-test its crisis plan, prepare spokespeople or think through how you would respond to a situation like this one, schedule a consultation. Preparation is always less expensive than recovery.